Related references
Note: Only part of the references are listed.Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
Muriel Elhai et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern
Michael Gernert et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Autologous Hematopoietic Stern Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis
Roni Shouval et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients
Dominique Farge et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis Data From Two Independent Cohorts
Minghua Wu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients
L. Michel et al.
BONE MARROW TRANSPLANTATION (2016)
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Romain Banchereau et al.
CELL (2016)
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
CHEST (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study
J. Baraut et al.
BONE MARROW TRANSPLANTATION (2014)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Similarity network fusion for aggregating data types on a genomic scale
Bo Wang et al.
NATURE METHODS (2014)
Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis
Lucille Desallais et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Association of Interferon- and Transforming Growth Factor β-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis
Romy B. Christmann et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Democratizing systems immunology with modular transcriptional repertoire analyses
Damien Chaussabel et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity
Carmelo Carmona-Rivera et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
Systemic Sclerosis and Lupus Points in an Interferon-Mediated Continuum
Shervin Assassi et al.
ARTHRITIS AND RHEUMATISM (2010)
Interferon-Regulated Chemokines as Biomarkers of Systemic Lupus Erythematosus Disease Activity A Validation Study
Jason W. Bauer et al.
ARTHRITIS AND RHEUMATISM (2009)
Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
Tobias Alexander et al.
BLOOD (2009)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus
Jason W. Bauer et al.
PLOS MEDICINE (2006)
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients
FK Tan et al.
RHEUMATOLOGY (2006)
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)
J Storek et al.
CLINICAL IMMUNOLOGY (2004)
Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation
EC Baechler et al.
GENES AND IMMUNITY (2004)
Role of monocyte chemoattractant protein-1 and its receptor, CCR-2, in the pathogenesis of bleomycin-induced scleroderma
T Yamamoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation
S Diehl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
